Yatin Suneja
Stock Analyst at Guggenheim
(4.27)
# 438
Out of 5,005 analysts
142
Total ratings
59.2%
Success rate
12.71%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $80 → $20 | $8.43 | +137.25% | 4 | Sep 30, 2025 | |
| ACET Adicet Bio | Reiterates: Buy | $7 | $0.83 | +738.83% | 2 | Sep 19, 2025 | |
| ARGX argenx SE | Reiterates: Buy | $1,070 | $800.00 | +33.75% | 13 | Sep 18, 2025 | |
| ROIV Roivant Sciences | Maintains: Buy | $15 → $21 | $16.17 | +29.87% | 3 | Sep 18, 2025 | |
| TRML Tourmaline Bio | Downgrades: Neutral | $55 → $48 | $47.90 | +0.21% | 4 | Sep 10, 2025 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $92 → $100 | $34.94 | +186.20% | 2 | Sep 9, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | $75 | $15.49 | +384.18% | 1 | Aug 18, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $25 → $15 | $2.44 | +514.75% | 6 | Aug 8, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $810 → $815 | $600.00 | +35.83% | 7 | Aug 4, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $165 → $175 | $137.03 | +27.71% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $101 | $83.92 | +20.35% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.87 | +433.88% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $18 | $4.02 | +347.76% | 2 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $90 | $30.94 | +190.89% | 13 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $13.10 | +121.37% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $12 | $12.21 | -1.72% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.93 | +281.68% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.58 | +532.91% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $16.90 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $21.76 | +106.80% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.83 | - | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $13.69 | +228.83% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $21.80 | -8.26% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.07 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $15.89 | +309.06% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $170 | $54.38 | +212.61% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $30.14 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $26.41 | +240.78% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $120.30 | +3.91% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.53 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $39.61 | +23.71% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $13.73 | +300.58% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $159.88 | +118.91% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.32 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $15.20 | +57.89% | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $106.79 | -68.16% | 2 | Jan 14, 2020 |
MoonLake Immunotherapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $8.43
Upside: +137.25%
Adicet Bio
Sep 19, 2025
Reiterates: Buy
Price Target: $7
Current: $0.83
Upside: +738.83%
argenx SE
Sep 18, 2025
Reiterates: Buy
Price Target: $1,070
Current: $800.00
Upside: +33.75%
Roivant Sciences
Sep 18, 2025
Maintains: Buy
Price Target: $15 → $21
Current: $16.17
Upside: +29.87%
Tourmaline Bio
Sep 10, 2025
Downgrades: Neutral
Price Target: $55 → $48
Current: $47.90
Upside: +0.21%
Dianthus Therapeutics
Sep 9, 2025
Maintains: Buy
Price Target: $92 → $100
Current: $34.94
Upside: +186.20%
Forte Biosciences
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $15.49
Upside: +384.18%
Cabaletta Bio
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.44
Upside: +514.75%
Regeneron Pharmaceuticals
Aug 4, 2025
Maintains: Buy
Price Target: $810 → $815
Current: $600.00
Upside: +35.83%
Neurocrine Biosciences
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $137.03
Upside: +27.71%
Jul 23, 2025
Maintains: Buy
Price Target: $50 → $101
Current: $83.92
Upside: +20.35%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $4.87
Upside: +433.88%
Jun 10, 2025
Reinstates: Buy
Price Target: $18
Current: $4.02
Upside: +347.76%
May 28, 2025
Maintains: Buy
Price Target: $54 → $90
Current: $30.94
Upside: +190.89%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $13.10
Upside: +121.37%
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $12.21
Upside: -1.72%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $3.93
Upside: +281.68%
Mar 26, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $1.58
Upside: +532.91%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $16.90
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $21.76
Upside: +106.80%
Mar 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.83
Upside: -
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $13.69
Upside: +228.83%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $21.80
Upside: -8.26%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.07
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $15.89
Upside: +309.06%
Aug 14, 2024
Maintains: Buy
Price Target: $155 → $170
Current: $54.38
Upside: +212.61%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $30.14
Upside: -
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $26.41
Upside: +240.78%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $120.30
Upside: +3.91%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.53
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $39.61
Upside: +23.71%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $13.73
Upside: +300.58%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $159.88
Upside: +118.91%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.32
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $15.20
Upside: +57.89%
Jan 14, 2020
Maintains: Buy
Price Target: $29 → $34
Current: $106.79
Upside: -68.16%